Wells Fargo
BGLC icon

Wells Fargo’s BioNexus Gene Lab BGLC Stock Holding History

Wells Fargo’s Portfolio BGLC Stock Details BGLC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Buy
+1
New +$3 ﹤0.01% 7092

Other funds holding BGLC

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's BGLC Position: Q1 2026 in Review

Wells Fargo opened a new position in BioNexus Gene Lab (BGLC) in Q1 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #7092 among its holdings.

2 funds tracked by Wall St. Rank hold BGLC as of Q1 2026.

  • Wells Fargo held 1 share of BioNexus Gene Lab worth $2 as of Q1 2026.
  • BioNexus Gene Lab was a new Wells Fargo position in Q1 2026.
  • BioNexus Gene Lab made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #7092 holding.
  • 2 funds tracked by Wall St. Rank held BioNexus Gene Lab as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.